GLP-1 Therapies: Targeting Metabolic Disease GLP-1 receptor agonists are prescription medicines designed to mimic...
TMLabs Blogs
People, AI and Science: Why Message Measurement Will Define the Next Era of Healthcare Innovation
Why Message Measurement Will Define the Next Era of Healthcare Innovation Artificial Intelligence is accelerating...
Beyond Clicks: Why Message Measurement Matters in the Generative Engine Optimization Era
A New Measurement Challenge Digital marketing has traditionally relied on measurable interactions: clicks, website...
Generative Engine Optimization (GEO) and the Rise of Invisible Clicks
The Search Landscape is Changing For more than two decades, digital success has been built around a simple journey: ...
People, Science & AI : Why the Biggest Challenge Isn’t Technology, It’s Translation
Part 1: Why the Biggest Challenge Isn't Technology It's Translation Every generation faces a defining challenge. For...
Synthetic Personas vs Evidence-Based Personas: Moving from “What They Say” to “What They Do”
The Evolution of Personas For years, personas have supported businesses to humanize their audiences. Traditionally,...
Beyond the Clinical Data: Why Patient, Consumer and HCP Conversations Matter in the Future of GLP-1s and Cancer Care
The Conversation Has Already Started Scientific conferences often spark new healthcare discussions, where healthcare...
GLP-1s Are Breaking Into New Territory: What ASCO 2026 Reveals About Their Potential in Oncology
A New Frontier for GLP-1 Therapies Few therapeutic classes have generated as much attention as GLP-1 therapies in...
GLP-1s Are Redefining More Than Healthcare – They are Reshaping Entire Industries
Healthcare Innovation with Wide Market Effects GLP-1 receptor agonists, initially developed for type 2 diabetes and...
Motivation and Behavior: The Influence of GLP-1 Therapies Beyond Metabolic Health
GLP-1: More Than a Metabolic Hormone Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly becoming one...
GLP-1s and the Information Explosion: When Consumer Curiosity Meets AI-Driven Health Decisions
The Rise of the Health-Seeking Consumer We are witnessing a fundamental shift: Patients are no longer simply passive...
Rethinking Persona Modeling in Pharma: A Missed Opportunity
The $20B Question: Why Behavior Still Feels Elusive US Pharma spends approximately $20 billion each year marketing to...





















